Veterinary Drugs
Veterinary drugs, also known as medicinal products for veterinary use, veterinary medicine or veterinary medicinal products (VMPs), are substances or combinations of substances to treat, prevent or diagnose disease in animals. The EU works to support the development and authorisation of safe, effective and quality veterinary medicinal products for food producing and companion animals, ensuring their availability and guaranteeing the highest level of public health, animal health and environment. The law governing veterinary medicinal products in the EU sets standards to ensure adequate health protection and established Maximum Residue Limits (MRL’s) for certain drugs in target tissues and animal species and has also identified pharmacologically active compounds that are prohibited and considered a hazard at any level (EU regulation EC 37/2010; Commission Decision 2003/181/EC; 21CFR Part 556 Tolerances for Residues of New Animal Drugs in Food). The current legal framework for veterinary medicinal products and medicated feed have been replaced by Regulation (EU) 2019/6 on veterinary medicinal products and Regulation (EU) 2019/4 on medicated feed; the new regulations will apply from 28 January 2022. Shimadzu is offering the full solution for veterinary drugs testing.
Multi-residue veterinary drug analysis of >200 compounds using MRM Spectrum mode by LC-MS/MS
Veterinary drugs are used for therapeutic, metaphylactic, prophylactic and growth promotion purposes. Shimadzu has developed a method using the highly sensitive and selective triple quadrupole mass spectrometer LCMS-8060 together with MRM Spectrum mode to reduce false positive and false negative reporting in multi-residue veterinary drug analysis of food samples such as beef, egg, milk, salmon and more.
Fast Quantitative Analysis of Aminoglycoside Antibiotic Residues in Meat, Eggs and Milk and Identity Confirmation with MRM Spectrum Mode
Aminoglycosides are an antibiotic family widely used for the treatment of bacterial infections in cattle, sheep, pigs and poultry. Regulatory agencies have set maximum residue limits (MRL) for these compounds after veterinary use. Aminoglycosides are very polar compounds, and usually require the use of undesirable ion-pairing reagents with LC-MS/MS.Shimadzu has developed a Method Package as a complete solution for the simultaneous quantitative analysis of all regulated aminoglycosides by HILIC/MS/MS.
LC/MS/MS Method Package for Aminoglycoside Antibiotics
Complete method for fast quantitative screening of 13 aminoglycosides in meat, eggs and milk. Increase identification confidence with MRM Spectrum mode and LabSolutions Insight™ Screening. No ion-pairing reagent required. Includes single sample preparation protocol usable for meat, eggs and milk.
LC/MS/MS Method Package for Veterinary Drugs Ver. 2
Veterinary drugs are used for therapeutic, metaphylactic, prophylactic and growth promotion purposes. To provide an assurance that food from animals is safe with regards to residues of veterinary medicines, regulatory authorities have established Maximum Residue Limits (MRL's) for certain drugs in target tissues and animal species. Some pharmacologically active compounds identified by regulatory authorities have been prohibited and maximum residue limits in foodstuffs of animal origin have been set in COMMISSION REGULATION (EU) No 37/2010 and published in the last consolidated version of 03/12/2020.
